ArticleClinical and translational medicine2025

Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement.

Carmen Navarrete-Sirvent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.